Vivos therapeutics closes $4 million private placement

Littleton, colo., nov. 02, 2023 (globe newswire) -- vivos therapeutics, inc. (“vivos” or the “company”) (nasdaq: vvos), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild-to-moderate obstructive sleep apnea (osa) and snoring in adults, announced that today it has closed a $4 million private placement previously announced on october 31, 2023.
VVOS Ratings Summary
VVOS Quant Ranking